Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2021 May;68(Suppl 2):e28473. doi: 10.1002/pbc.28473

Table 1.

Image-defined risk factors (IDRFs) in neuroblastic tumors

Ipsilateral tumour extension within two body compartments
Neck
Tumour encasing carotid and/or vertebral artery and/or internal jugular vein
Tumour extending to base of the skull
Tumour compressing the trachea

Cervico-thoracic junction
Tumour encasing brachial plexus roots
Tumour encasing subclavian vessels and/or vertebral and/or carotid artery
Tumour compressing the trachea

Thorax
Tumour encasing the aorta and/or major branches
Tumour compressing the trachea and/or principal bronchi
Lower mediastinal tumour, infiltrating the costo-vertebral junction between T9 and T12

Thoraco-abdominal
Tumour encasing the aorta and/or the vena cava

Abdomen/pelvis
Tumour infiltrating the porta hepatis and/or the hepatoduodenal ligament
Tumour encasing branches of the superior mesenteric artery and the mesenteric root
Tumour encasing the origin of celiac axis and/or of the superior mesenteric artery
Tumour invading one or both renal pedicles
Tumour encasing the aorta and/or the vena cava
Tumour encasing the iliac vessels
Pelvic tumour across the sciatic notch

Intraspinal tumour
Extension, regardless of location, provided that more than one-third of the spinal canal in the axial plane is invaded and/or the perimedullary leptomeningeal spaces are not visible and/or the spinal cord signal is abnormal

Infiltration of adjacent organs/structures
Pericardium, diaphragm, kidney, liver, duodeno-pancreatic block and mesentery

Conditions to be recorded, but not considered as IDRFs
Multifocal primary tumours
Pleural effusion, with or without malignant cells
Ascites, with or without malignant cells